Evidence map›Paper›PMID 37700343›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2023

Clinical application of Al

Zhehao Lyu, Wei Han, Qi Zhang, Hongyue Zhao, Shan Liu, Yan Wang, Jin He, Changjiu Zhao, Lin Tian, Peng Fu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. [Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  3. Diagnostic Efficacy of FAPI-PET/CT Versus [Diagnostics (Basel, Switzerland) · 2026
    Review
  4. Head-to-head comparison of [Frontiers in medicine · 2026
    Article
  5. Evaluating the diagnostic value ofJapanese journal of radiology · 2025
    Article
  6. Frontiers in oncology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Theranostics · 2024
    Article
  11. Comparative analysis of two timepoints on [European journal of hybrid imaging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhehao Lyu *The Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Wei Han *The Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Qi ZhangThe Department of Radiology, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Hongyue ZhaoThe Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Shan LiuThe Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Yan WangThe Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Jin HeThe Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Changjiu ZhaoThe Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China.
Lin Tian *The Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China. tianlin6225108@163.com.
Peng Fu *The Department of Nuclear Medicine, the First Affiliated Hospital of Harbin Medical University, Postal Street, Harbin, Heilongjiang Province, China. fupeng0451@163.com.
First Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to investigate the ability of Al

methodsProspective analysis of Al

resultsA total of 31 patients with pancreatic carcinoma (all were adenocarcinoma) underwent Al

conclusionAl

trial registrationChinese Clinical Trial Registry, ChiCTR2100051406. Registered 23 September 2021, https://www.chictr.org.cn/showproj.html?proj=133033.

Indexed as

AdenocarcinomaPancreatic NeoplasmsAgedFemaleFluorodeoxyglucose F18Heterocyclic Compounds, 1-RingHumansInflammationMaleMiddle AgedNeoplasm StagingPositron Emission Tomography Computed Tomography1,4,7-triazacyclononane-N,N',N''-triacetic acidFluorodeoxyglucose F18Heterocyclic Compounds, 1-Ring[18F]FDGAl18F-NOTA-FAPIPancreatic cancerPET/CTStaging

Identifiers

PMID37700343
PMCPMC10496317
OpenAlexW4386688973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.